2025 ICD-10-CM code L73.2

Hidradenitis suppurativa, also known as Verneuil's disease or acne inversa, is a chronic skin condition characterized by painful nodules, abscesses, and scarring in areas with apocrine sweat glands.

Appropriate coding of hidradenitis suppurativa requires accurate documentation of the condition's characteristics and severity to ensure the correct ICD-10 code (L73.2) is applied.Consult the latest ICD-10-CM coding guidelines for specific rules and instructions.

Modifiers are not applicable to ICD-10 codes.They modify CPT and HCPCS codes to provide additional information about the service performed.

Medical necessity for treatment of hidradenitis suppurativa is established based on the patient's clinical presentation. Documentation should support the severity of symptoms, impact on daily living, and the need for treatment to alleviate pain, prevent infection, and improve functional status.The treatment plan should be tailored to the patient's individual needs, justifying the medical necessity of specific services and medications.

The clinical responsibility for hidradenitis suppurativa varies depending on the severity and treatment approach.A dermatologist is usually involved in diagnosis and management.Other specialists (e.g., general surgeon, plastic surgeon) may be involved in surgical procedures.

IMPORTANT No alternate codes provided in source data.

In simple words: Hidradenitis suppurativa is a long-term skin problem causing painful lumps, boils, and scarring, mostly in areas like armpits and groin. These lumps can become infected and leak pus.It's often treated with medicine or surgery, depending on severity.

Hidradenitis suppurativa (HS), also known as Verneuil's disease or acne inversa, is a chronic inflammatory skin condition affecting apocrine sweat glands.It typically presents with recurrent nodules, abscesses, and sinus tracts, often located in intertriginous areas such as the axillae, groin, perineum, buttocks, and mammary folds.Lesions can be painful and may drain pus.Chronic HS leads to significant scarring and potential functional impairment.Diagnosis requires the presence of characteristic lesions in typical locations, with a chronic or recurrent course.Severity varies, influencing treatment options ranging from topical therapies (antibiotics, washes) and systemic medications (antibiotics, corticosteroids) to surgical interventions.

Example 1: A 35-year-old woman presents with recurrent painful nodules and abscesses in her axillary region.She reports a history of similar episodes for several years.Diagnosis of hidradenitis suppurativa is made, and she is prescribed antibiotics and topical treatments., A 40-year-old obese man develops severe hidradenitis suppurativa in his groin area, requiring surgical intervention to drain abscesses and debride affected tissue. Post-operative care includes antibiotics and wound management., A 28-year-old woman with mild hidradenitis suppurativa is managed conservatively with topical antibiotics and lifestyle modifications (weight loss, smoking cessation) to reduce inflammation and prevent recurrences.

Detailed history of the condition including onset, duration, location, and recurrence.Physical examination findings documenting lesions, their characteristics (size, number, location, drainage), and presence of scarring.Diagnostic imaging (if performed) may be included to assist in identifying abscesses or sinus tracts.Documentation of treatment provided, including medication prescribed and surgical procedures, should be thoroughly documented.

** Accurate coding of hidradenitis suppurativa relies heavily on comprehensive documentation.The severity of the condition and the associated treatment plan significantly impact reimbursement. Always refer to the latest coding guidelines and payer-specific rules.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.